Search:

Recent News:

Adeona Pharmaceuticals Announces Clinical Update and Third Quarter 2008 Results

Adeona Pharmaceuticals Announces Issuance Of US Patent For Oral Tiomolibdate Diammonium For Alzheimer’s Disease

Adeona Pharmaceuticals To Present At Rodman & Renshaw Healthcare Conference

Adeona Pharmaceuticals’ Oral dnaJP1 Phase II Clinical Findings Presented At The American College of Rheumatology Annual Meeting

Pipex PharmaceuticalsÕ Oral TRIMESTA Phase IIa Clinical And Preclinical Findings Presented At World Congress On Treatment And Research In Multiple Sclerosis Meeting

Pipex Pharmaceuticals Acquires Late-Stage Oral Phase II Candidate for Rheumatoid Arthritis

Pipex Pharmaceuticals Announces Clinical Update and Second Quarter 2008 Results

Pipex Pharmaceuticals Announces Results of Eighty Patient, Six Month, Prospective, Randomized, Double-Blind Clinical Trial of Oral Zinthionein for Dry Age-Related Macular Degeneration (AMD)

Pipex Pharmaceuticals Appoints Co-Founder and Vice Chairman Nicholas Stergis as Chief Executive Officer

Pipex Pharmaceuticals Executes Option to License Oral Flupirtine Patent Estate for Diabetes, Diabetic Retinopathy, Retinitis Pigmentosa and Glaucoma

Pipex Pharmaceuticals Announces Issuance of Additional US Patent Covering CD4 Inhibitor Molecules

Pipex Pharmaceuticals Announces Clinical Update and First Quarter 2008 Results

Pipex Pharmaceuticals To Provide Clinical Update and Report First Quarter

Pipex Pharmaceuticals Announces Fourth Quarter and Year End 2007 Results

Pipex Pharmaceuticals Provides Update on COPREXA (Oral Tetrathiomolybdate) New Drug Application

Chief Science Officer Dr. David A. Newsome on CBS news affiliate for "Copper, drinking water and vitamins"

Pipex webcast at Rodman and Renshaw Healthcare Conference Nov 06, 2007

Pipex Pharmaceuticals Rings Opening Bell at the American Stock Exchange.

Noble Financial 007 August 20, 2007

Financial Results for Fourth Quarter and Year End 2006

Recent Webcast:

Third Quarter Conference Call from 4:00pm EST 11-14-08.

Stock:

AMEX:AEN 0.30
Change: -0.0901
11/21/2008 1:14pm
Open: 0.30
High: 0.42 Low: 0.27
Volume: 10890

20 minute delayed data provided by Yahoo. Adeona Pharmaceuticals makes no claims concerning the accuracy of the information provided on these pages, and will not be held liable for any use of this information. Note: Historical and current stock price performance data is not necessarily indicative of future performance.

You are here: Home »

Search our Site

Search our site using the search tools below.